Evidence map›Paper›PMID 27342962›Full record

ArticleJournal of gastrointestinal cancer2016

DNA Damage Is a Potential Marker for TP53 Mutation in Colorectal Carcinogenesis.

José Ricardo Scalise, Regina Caeli Guerra Poças, Thamy Pelatieri Caneloi, Camila Oliveira Lopes, Danilo Toshio Kanno, Mayara Gonçalves Marques, Júlio Cesar Martins Valdivia, Felipe Rodrigues Maximo, José Aires Pereira, Marcelo Lima Ribeiro and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of gastrointestinal cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. The Anti-Inflammatory Properties of Licorice (International journal of molecular sciences · 2022
    Review
  4. Article
  5. Review
  6. Review
  7. Current and future biomarkers in colorectal cancer.Annals of gastroenterology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

José Ricardo ScalisePostgraduate Programme Strictu Senso in Health Science, Sao Francisco University Medical School, Sao Paulo, Brazil.
Regina Caeli Guerra PoçasPostgraduate Programme Strictu Senso in Health Science, Sao Francisco University Medical School, Sao Paulo, Brazil.
Thamy Pelatieri CaneloiScientific Initiation Student, Scientific Initiation Programme, Sao Francisco University Medical School, Sao Paulo, Brazil.
Camila Oliveira LopesScientific Initiation Student, Scientific Initiation Programme, Sao Francisco University Medical School, Sao Paulo, Brazil.
Danilo Toshio KannoScientific Initiation Student, Scientific Initiation Programme, Sao Francisco University Medical School, Sao Paulo, Brazil.
Mayara Gonçalves MarquesScientific Initiation Student, Scientific Initiation Programme, Sao Francisco University Medical School, Sao Paulo, Brazil.
Júlio Cesar Martins ValdiviaScientific Initiation Student, Scientific Initiation Programme, Sao Francisco University Medical School, Sao Paulo, Brazil.
Felipe Rodrigues MaximoScientific Initiation Student, Scientific Initiation Programme, Sao Francisco University Medical School, Sao Paulo, Brazil.
José Aires PereiraDepartment of Pathology, Sao Francisco University Medical School, Sao Paulo, Brazil.
Marcelo Lima RibeiroPostgraduate Programme Strictu Senso in Health Science, Sao Francisco University Medical School, Sao Paulo, Brazil.
Denise Gonçalves PriolliPostgraduate Programme Strictu Senso in Health Science, Sao Francisco University Medical School, Sao Paulo, Brazil. depriolli@terra.com.br.
Universidade São Francisco · BRHospital São Vicente · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe ability to measure oxidative DNA damage in a tissue allows establishment of the relationship between DNA damage and mutations in normal and neoplastic cells. It is well known that TP53 is a key inhibitor of tumor development and preserves the genome integrity in each cell. The aim of the present study was to investigate the relationship between DNA damage and TP53 mutation in colorectal adenoma and adenocarcinoma, and the value of DNA damage as potential marker of TP53 mutation in non-tumor tissues adjacent to colon malignant lesions.

methodsTissue samples were obtained by colonoscopy from patients with adenoma and/or adenocarcinoma and from healthy volunteers. Diagnosis was defined by histopathology. Immunohistochemistry with computer-assisted image analysis was performed to quantify TP53 mutation. Oxidative DNA damage was determined by comet assay. Statistical analyses were performed with 5 % of significance level.

resultsThe TP53 level was higher in non-tumor tissues from tumor patients than in normal tissues from healthy volunteers (p = 0.01). Likewise, higher TP53 levels were observed in tumor tissues compared with the non-tumor tissues (p = 0.00). Oxidative DNA damage levels were higher in tumor tissues than in non-tumor tissues (p = 0.00). The amount of TP53 (p = 0.00) and oxidative DNA damage (p = 0.00) in normal and tumor tissue was related. The relationship between oxidative DNA damage and TP53 mutation was demonstrated in all samples (p = 0.00).

conclusionOxidative DNA damage is an intervening variable for TP53 mutation in colorectal adenoma-carcinoma. Our data suggests that oxidative DNA damage is a potential marker of TP53 mutation in colorectal carcinogenesis.

Indexed as

DNA DamageColorectal NeoplasmsFemaleGenes, p53HumansImmunohistochemistryMaleMutationTumor Suppressor Protein p53TP53 protein, humanTumor Suppressor Protein p53AdenocarcinomaAdenomaDNA damageImmunohistochemistryTumor suppressor protein p53

Identifiers

PMID27342962
OpenAlexW2460276162

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.